Bios Fund Ii Nt, Lp - Net Worth and Insider Trading

Bios Fund Ii Nt, Lp Net Worth

The estimated net worth of Bios Fund Ii Nt, Lp is at least $1 Million dollars as of 2024-05-25. Bios Fund Ii Nt, Lp is the Director, 10% Owner of IN8bio Inc and owns about 997,433 shares of IN8bio Inc (INAB) stock worth over $1 Million. Details can be seen in Bios Fund Ii Nt, Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bios Fund Ii Nt, Lp has not made any transactions after 2022-08-29 and currently still holds the listed stock(s).

Transaction Summary of Bios Fund Ii Nt, Lp

To

Bios Fund Ii Nt, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bios Fund Ii Nt, Lp owns 4 companies in total, including Lantern Pharma Inc (LTRN) , Cognition Therapeutics Inc (CGTX) , and IN8bio Inc (INAB) among others .

Click here to see the complete history of Bios Fund Ii Nt, Lp’s form 4 insider trades.

Insider Ownership Summary of Bios Fund Ii Nt, Lp

Ticker Comapny Transaction Date Type of Owner
LTRN Lantern Pharma Inc 2022-09-02 10 percent owner
CGTX Cognition Therapeutics Inc 2022-11-15 10 percent owner
INAB IN8bio Inc 2022-08-29 director & 10 percent owner
2023-06-15 10 percent owner

Bios Fund Ii Nt, Lp Latest Holdings Summary

Bios Fund Ii Nt, Lp currently owns a total of 1 stock. Bios Fund Ii Nt, Lp owns 997,433 shares of IN8bio Inc (INAB) as of August 29, 2022, with a value of $1 Million.

Latest Holdings of Bios Fund Ii Nt, Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INAB IN8bio Inc 2022-08-29 997,433 1.01 1,007,407

Holding Weightings of Bios Fund Ii Nt, Lp


Bios Fund Ii Nt, Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Bios Fund Ii Nt, Lp has made a total of 3 transactions in IN8bio Inc (INAB) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in IN8bio Inc is the acquisition of 51,214 shares on August 29, 2022, which cost Bios Fund Ii Nt, Lp around $103,452.

Insider Trading History of Bios Fund Ii Nt, Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bios Fund Ii Nt, Lp Trading Performance

GuruFocus tracks the stock performance after each of Bios Fund Ii Nt, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bios Fund Ii Nt, Lp is -24.58%. GuruFocus also compares Bios Fund Ii Nt, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bios Fund Ii Nt, Lp within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bios Fund Ii Nt, Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bios Fund Ii Nt, Lp

Average Return

Average return per transaction

Outperforming Transactions

0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.58
Relative Return to S&P 500(%) 18.16

Bios Fund Ii Nt, Lp Ownership Network

Ownership Network List of Bios Fund Ii Nt, Lp

No Data

Ownership Network Relation of Bios Fund Ii Nt, Lp


Bios Fund Ii Nt, Lp Owned Company Details

What does Lantern Pharma Inc do?

Who are the key executives at Lantern Pharma Inc?

Bios Fund Ii Nt, Lp is the 10 percent owner of Lantern Pharma Inc. Other key executives at Lantern Pharma Inc include 10 percent owner Leslie W. Kreis , 10 percent owner Bios Fund I, Lp , and 10 percent owner Fletcher Aaron G.l. .

Lantern Pharma Inc (LTRN) Insider Trades Summary

Over the past 18 months, Bios Fund Ii Nt, Lp made no insider transaction in Lantern Pharma Inc (LTRN). Other recent insider transactions involving Lantern Pharma Inc (LTRN) include a net sale of 348,237 shares made by Leslie W. Kreis , and a net sale of 348,237 shares made by Bios Fund I, Lp .

In summary, during the past 3 months, insiders sold 288,000 shares of Lantern Pharma Inc (LTRN) in total and bought 0 shares, with a net sale of 288,000 shares. During the past 18 months, 696,474 shares of Lantern Pharma Inc (LTRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 696,474 shares.

Lantern Pharma Inc (LTRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lantern Pharma Inc Insider Transactions

No Available Data

Bios Fund Ii Nt, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Bios Fund Ii Nt, Lp. You might contact Bios Fund Ii Nt, Lp via mailing address: 1401 Foch Street, Suite 140, Fort Worth Tx 76107.

Discussions on Bios Fund Ii Nt, Lp

No discussions yet.